Literature DB >> 33557156

Hashimoto's Thyroiditis and Graves' Disease in Genetic Syndromes in Pediatric Age.

Celeste Casto1, Giorgia Pepe1, Alessandra Li Pomi1, Domenico Corica1, Tommaso Aversa1, Malgorzata Wasniewska1.   

Abstract

Autoimmune thyroid diseases (AITDs), including Hashimoto's thyroiditis (HT) and Graves' disease (GD), are the most common cause of acquired thyroid disorder during childhood and adolescence. Our purpose was to assess the main features of AITDs when they occur in association with genetic syndromes. We conducted a systematic review of the literature, covering the last 20 years, through MEDLINE via PubMed and EMBASE databases, in order to identify studies focused on the relation between AITDs and genetic syndromes in children and adolescents. From the 1654 references initially identified, 90 articles were selected for our final evaluation. Turner syndrome, Down syndrome, Klinefelter syndrome, neurofibromatosis type 1, Noonan syndrome, 22q11.2 deletion syndrome, Prader-Willi syndrome, Williams syndrome and 18q deletion syndrome were evaluated. Our analysis confirmed that AITDs show peculiar phenotypic patterns when they occur in association with some genetic disorders, especially chromosomopathies. To improve clinical practice and healthcare in children and adolescents with genetic syndromes, an accurate screening and monitoring of thyroid function and autoimmunity should be performed. Furthermore, maintaining adequate thyroid hormone levels is important to avoid aggravating growth and cognitive deficits that are not infrequently present in the syndromes analyzed.

Entities:  

Keywords:  22q11.2 deletion syndrome; Down syndrome; Graves’ disease; Hashimoto’s thyroiditis; Klinefelter syndrome; Prader–Willi syndrome; RASopathies; Turner syndrome; Williams syndrome; genetic syndromes

Mesh:

Year:  2021        PMID: 33557156      PMCID: PMC7913917          DOI: 10.3390/genes12020222

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  180 in total

1.  Early thyroxine treatment in Down syndrome and thyroid function later in life.

Authors:  Nitash Zwaveling-Soonawala; M Emma Witteveen; Jan Pieter Marchal; Femke C C Klouwer; Nadine A Ikelaar; Anne M J B Smets; Rick R van Rijn; Erik Endert; Eric Fliers; A S Paul van Trotsenburg
Journal:  Eur J Endocrinol       Date:  2017-01-30       Impact factor: 6.664

2.  An isolated Xp deletion is linked to autoimmune diseases in Turner syndrome.

Authors:  Judith Stoklasova; Jirina Zapletalova; Zdenek Frysak; Vaclav Hana; Jan Cap; Marketa Pavlikova; Ondrej Soucek; Jan Lebl
Journal:  J Pediatr Endocrinol Metab       Date:  2019-05-27       Impact factor: 1.634

3.  Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies.

Authors:  Caio R D C Quaio; Jozélio F Carvalho; Clovis A da Silva; Cleonice Bueno; Amanda S Brasil; Alexandre C Pereira; Alexander A L Jorge; Alexsandra C Malaquias; Chong A Kim; Débora R Bertola
Journal:  Am J Med Genet A       Date:  2012-04-09       Impact factor: 2.802

4.  Diabetic ketoacidosis, thyroiditis and alopecia areata in a child with Down syndrome.

Authors:  Ozgur Pirgon; Mehmet Emre Atabek; Ahmet Sert
Journal:  Indian J Pediatr       Date:  2009-12-11       Impact factor: 1.967

5.  Anti-natrium/iodide symporter antibodies and other anti-thyroid antibodies in children with Turner's syndrome.

Authors:  Anna M Kucharska; Barbara Czarnocka; Urszula Demkow
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 6.  Neurofibromatosis type 1.

Authors:  Jacqueline L Anderson; David H Gutmann
Journal:  Handb Clin Neurol       Date:  2015

7.  Hypothyroidism and levothyroxine-responsive liver dysfunction in a patient with ring chromosome 18 syndrome.

Authors:  Kazuhiro Ohkubo; Kenji Ihara; Shouichi Ohga; Masataka Ishimura; Toshiro Hara
Journal:  Thyroid       Date:  2012-09-04       Impact factor: 6.568

8.  Thyroid dysfunction and high thyroid stimulating hormone levels in children with Down's syndrome.

Authors:  Laura Gruñeiro de Papendieck; A Chiesa; M G Bastida; G Alonso; G Finkielstain; J J Heinrich
Journal:  J Pediatr Endocrinol Metab       Date:  2002 Nov-Dec       Impact factor: 1.634

9.  CD4+ FOXP3+ Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome.

Authors:  Young Ah Lee; Hang-Rae Kim; Jeong Seon Lee; Hae Woon Jung; Hwa Young Kim; Gyung Min Lee; Jieun Lee; Ji Hyun Sim; Sae Jin Oh; Doo Hyun Chung; Choong Ho Shin; Sei Won Yang
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

10.  McCune-Albright Syndrome With Unremitting Hyperthyroidism at Early Age: Management Perspective for Early Thyroidectomy.

Authors:  Nadia Merchant; Johanna M Viau-Colindres; Kelly A Hicks; Andrea E Balazs; David E Wesson; Monica E Lopez; Lefkothea Karaviti
Journal:  Glob Pediatr Health       Date:  2019-09-09
View more
  4 in total

Review 1.  Thyroid abnormalities in children with Down syndrome at St. Paul's hospital millennium medical college, Ethiopia.

Authors:  Birtukan Mulu; Bereket Fantahun
Journal:  Endocrinol Diabetes Metab       Date:  2022-04-14

2.  A case of Turner's syndrome with Graves' disease and primary hyperparathyroidism.

Authors:  Shigeru Nagaki; Emiko Tachikawa; Hitomi Kodama; Takao Obara; Makiko Osawa; Satoru Nagata
Journal:  SAGE Open Med Case Rep       Date:  2021-11-30

3.  Serum Levels of CXCL-13, RBP-4, and IL-6, and Correlation Analysis of Patients with Graves' Disease.

Authors:  Yanqin Hu; Yue Sun; Yuxuan Huang; Qiuxia Liu; Fan Ren
Journal:  Emerg Med Int       Date:  2022-08-12       Impact factor: 1.621

4.  Special Issue: Autoimmune Disease Genetics.

Authors:  Malgorzata Gabriela Wasniewska; Artur Bossowski
Journal:  Genes (Basel)       Date:  2021-11-30       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.